Waypoint Wealth Counsel’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.19M Sell
9,896
-695
-7% -$80.2K 0.62% 24
2025
Q4
$1.11M Buy
10,591
+727
+7% +$68.2K 0.41% 43
2025
Q3
$828K Buy
9,864
+1,055
+12% +$86.9K 0.33% 48
2025
Q2
$697K Buy
8,809
+5,481
+165% +$436K 0.35% 47
2025
Q1
$299K Buy
3,328
+322
+11% +$30.1K 0.19% 75
2024
Q4
$299K Buy
3,006
+127
+4% +$13.1K 0.2% 71
2024
Q3
$327K Sell
2,879
-47
-2% -$5.58K 0.22% 68
2024
Q2
$362K Buy
2,926
+19
+0.7% +$2.45K 0.28% 56
2024
Q1
$384K Buy
2,907
+82
+3% +$10.1K 0.3% 54
2023
Q4
$308K Sell
2,825
-370
-12% -$38.4K 0.26% 66
2023
Q3
$329K Buy
3,195
+1
+0% +$108 0.31% 54
2023
Q2
$369K Sell
3,194
-11
-0.3% -$1.25K 0.33% 55
2023
Q1
$341K Buy
3,205
+48
+2% +$5.18K 0.26% 59
2022
Q4
$350K Buy
+3,157
New +$323K 0.28% 66

Other funds holding MRK

Waypoint Wealth Counsel's MRK Position: Q1 2026 in Review

Waypoint Wealth Counsel reduced its Merck (MRK) stake by 6.6% in Q1 2026, selling an estimated $80.2K and leaving 9,896 shares worth $1.19M. The position accounts for 0.62% of the portfolio, ranked #24.

Waypoint Wealth Counsel first reported a position in MRK in Q4 2022 and has held it in 14 quarters since. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Waypoint Wealth Counsel held 9,896 shares of Merck worth $1.19M as of Q1 2026.
  • Waypoint Wealth Counsel sold 695 Merck shares in Q1 2026, an estimated $80.2K.
  • Merck made up 0.62% of Waypoint Wealth Counsel's portfolio in Q1 2026, its #24 holding.
  • Waypoint Wealth Counsel first reported a position in Merck in Q4 2022 and has held it in 14 quarters since.
  • 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Waypoint Wealth Counsel's 13F filing for Q1 2026, filed 23 Apr 2026.